What do you think? Take A Moment To Read: KalVista Pharmaceuticals Inc (KALV) Stock

H.C. Wainwright raised the price target for the KalVista Pharmaceuticals Inc (NASDAQ:KALV) stock to “a Buy”. The rating was released on June 15, 2020, according to finviz. The research report from Needham has initiated the stock to Buy, with a price target set at $35. The stock was initiated by Jefferies, who disclosed in a […]